In Reply

dc.contributor.authorAsfuroğlu, Mahmut
dc.contributor.authorÇavdarlı, Büşranur
dc.contributor.authorGürbüz Koz, Özlem
dc.contributor.authorYarangümeli, Ahmet
dc.contributor.authorÖzdemir, Emine
dc.date.accessioned2019-05-13T08:58:56Z
dc.date.available2019-05-13T08:58:56Z
dc.date.issued2017
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü
dc.description.abstractI am thankful to you for giving me this opportunity to respond this letter to the editor. I read the recent article by Yılmaz and colleagues entitled “LOXL1 gene analysis in Turkish patients with exfoliation glaucoma.” In this study they analyzed whole LOXL1 gene by sequence analysis to detect any mutations or additional polymorphisms with pseudoexfoliation (PEX) glaucoma in 48 Turkish patients
dc.identifier.citationAsfuroğlu, M., Çavdarlı, B., Gürbüz Koz, Ö., Yarangümeli, A., Özdemir, E. (2017). In Reply. Journal of Glaucoma, 26(7), 685-688.
dc.identifier.doi10.1097/IJG.0000000000000673
dc.identifier.endpage686en_US
dc.identifier.issn1057-0829
dc.identifier.issue7en_US
dc.identifier.scopusqualityQ2
dc.identifier.startpage685en_US
dc.identifier.urihttps://doi.org/10.1097/IJG.0000000000000673
dc.identifier.urihttps://hdl.handle.net/11491/1224
dc.identifier.volume26en_US
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherLippincott Williams and Wilkins
dc.relation.ispartofJournal of Glaucoma
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subject[Belirlenecek]en_US
dc.titleIn Reply
dc.typeOther

Dosyalar